Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
Balloon battle: which device best opens tiny heart arteries?
Disease control OngoingThis study compares two types of drug-coated balloons used to open blocked small arteries in the heart. About 180 adults with coronary artery disease will be randomly assigned to receive one of the two balloons. The goal is to see which balloon better prevents future heart proble…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
New heart-mapping tech tested in 550 patients to improve AFib treatment
Disease control OngoingThis study follows 550 adults with atrial fibrillation who are getting a standard heart ablation procedure using the FARAPULSE system and a new mapping tool called FARAVIEW. The goal is to see how safe and effective the procedure is over one year, and to understand what factors a…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
New combo therapy aims to shrink liver tumors
Disease control OngoingThis study tests a two-step treatment for liver cancer. First, tiny radioactive beads (TheraSphere) are injected into the liver to target tumors. Then, two immunotherapy drugs (durvalumab and tremelimumab) are given to boost the immune system. The goal is to see if this combinati…
Phase: PHASE2 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
Freezing away heart flutters: new device offers hope for AFib patients
Disease control OngoingThis study tests a freezing technique (cryoablation) to treat a common heart rhythm problem called paroxysmal atrial fibrillation (AFib). About 200 people who have not been helped by medication will undergo a procedure to freeze small areas of heart tissue, aiming to stop the irr…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New registry monitors penile implants in real life
Disease control ENROLLING_BY_INVITATIONThis study is a registry that collects real-world information on the safety and effectiveness of Boston Scientific penile prostheses for erectile dysfunction. It will enroll about 450 men who are already scheduled to receive the implant. Researchers will track changes in erectile…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
Zap or pills? new study tests First-Line heart ablation for AFib
Disease control OngoingThis study compares a new procedure called pulsed field ablation (PFA) to standard anti-arrhythmic drugs as the first treatment for people with persistent atrial fibrillation (a type of irregular heartbeat). About 484 participants will be randomly assigned to receive either the P…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
New balloon treatment could prevent repeat heart procedures
Disease control OngoingThis study tests a special balloon coated with a drug (paclitaxel) to treat heart arteries that have narrowed again after a stent was placed. About 600 adults will be randomly assigned to get either the drug-coated balloon or a standard balloon procedure. The goal is to see if th…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Zapping a nerve to help failing hearts
Disease control OngoingThis study tested whether stimulating the vagus nerve in the neck could help people with advanced heart failure. 118 participants received an implanted device that sends mild electrical pulses to the nerve. The goal was to see if this therapy could improve heart size and function…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
New radiation beads take on chemo for untreatable liver cancer
Disease control OngoingThis study compares a new treatment called TheraSphere (tiny radioactive beads) against standard chemoembolization for people with liver cancer that cannot be removed by surgery. About 92 Chinese adults with early-to-mid stage liver cancer will be randomly assigned to one of the …
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
New radiation beads aim to control prostate cancer safely
Disease control OngoingThis study tests the safety of a device called TheraSphere for men with localized prostate cancer. It uses tiny radioactive beads to deliver radiation directly to the tumor. The goal is to find the highest safe dose and see how well patients tolerate it. 36 participants will be f…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Heart valve trial halted: ACURATE device discontinued after testing in nearly 2,000 patients
Disease control OngoingThis study tested a new replacement heart valve (ACURATE) in nearly 2,000 people with severe aortic stenosis, a condition where the heart's main valve narrows and restricts blood flow. The goal was to see if the device was safe and effective at improving survival and reducing com…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Could a single pill replace two after heart implant? major trial seeks safer stroke prevention
Disease control OngoingThis study tests whether people with atrial fibrillation can take just one blood thinner or aspirin instead of two drugs after getting a WATCHMAN FLX Pro device to close a heart pouch. The goal is to see if these simpler plans are as safe and effective at preventing stroke and ma…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New balloon could unclog heart stents without extra surgery
Disease control OngoingThis study tests a special balloon coated with a drug (paclitaxel) to reopen heart stents that have become blocked again. About 20 adults with in-stent restenosis will receive the balloon treatment or standard care. The goal is to see if the balloon safely restores blood flow and…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Wireless heart devices team up to zap deadly rhythms
Disease control OngoingThis study tests a new system where two heart devices—a tiny pacemaker and a shock box under the skin—talk to each other to stop dangerous fast heartbeats. About 297 people with heart rhythm problems are taking part. The goal is to see if the system works safely and effectively w…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Heart device may rival pills for AFib stroke risk
Disease control OngoingThis study tests if a device called WATCHMAN FLX, which closes a small pouch in the heart, is a good alternative to daily blood thinners for preventing strokes in people with a common heart rhythm problem called atrial fibrillation. About 3000 participants are involved. The goal …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Spinal implant study tracks 5-year relief for leg pain sufferers
Disease control OngoingThis study follows 166 people aged 45+ who received the Superion implant to treat lumbar spinal stenosis, a condition that narrows the spine and causes leg pain. The goal is to see if the implant provides lasting symptom relief and avoids complications or additional surgeries ove…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New Drug-Coated device aims to unclog dialysis lifelines
Disease control OngoingThis study tests a treatment called BSJ020R for people whose dialysis fistulas are narrowing or blocking up. The goal is to see if it can keep the fistula open longer without needing another procedure. About 186 adults with mature fistulas that have been working for at least two …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New study tests best way to treat dangerous lung clots
Disease control OngoingThis study compares two treatments for people with a serious type of blood clot in the lungs (pulmonary embolism). Half of the 544 participants will receive standard blood thinners, while the other half will get blood thinners plus a special device that uses ultrasound to help di…
Phase: PHASE4 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New heart procedure tested for safety in 228 patients with irregular heartbeat
Disease control OngoingThis study follows 228 people with paroxysmal atrial fibrillation (a type of irregular heartbeat) who received a treatment called FARAPULSE pulsed field ablation. The goal is to see if the procedure is safe and effectively stops abnormal heart rhythms for at least a year. Partici…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
Tiny ring aims to repair leaky heart valve without open surgery
Disease control OngoingThis study tests a new device called the Millipede Ring, which is placed inside the heart to help a leaky mitral valve close better. It is for people with moderate to severe functional mitral regurgitation who still have symptoms despite medication. The main goal is to see if the…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Steam vs. pills: new study tests better fix for enlarged prostate in active men
Disease control OngoingThis study compares a minimally invasive water vapor treatment (REZŪM) to a two-drug combination for men with an enlarged prostate whose symptoms didn't improve with one drug. The goal is to see which approach better relieves urinary symptoms and preserves sexual function. About …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New heart procedure tracked in thousands to see if it keeps rhythm normal
Disease control OngoingThis study follows over 1,100 people with atrial fibrillation who received a new treatment called FARAPULSE pulsed field ablation. The procedure uses electrical pulses to destroy tiny areas of heart tissue causing irregular rhythm. Researchers are watching for safety issues and h…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 06, 2026 16:00 UTC
-
Gel shield could spare prostate cancer patients from radiation side effects
Disease control OngoingThis study tests a gel called SpaceIT that is injected between the prostate and rectum before radiation therapy for prostate cancer. The gel creates space to reduce radiation reaching the rectum, aiming to prevent side effects. About 230 men with low- to intermediate-risk prostat…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New stent aims to ease jaundice in cancer patients
Symptom relief TerminatedThis study looks at how well a special stent (Hot AXIOS) works to drain blocked bile ducts in people with cancer, after the usual procedure (ERCP) fails. The goal is to see if it improves quality of life, especially jaundice symptoms, over two months. About 162 adults with malign…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 26, 2026 03:12 UTC
-
New stent procedure offers hope for eating again in advanced cancer
Symptom relief TerminatedThis study tests a new way to help people with advanced cancer who cannot eat because their stomach is blocked. Doctors use a special tube (stent) placed with a scope to create a new opening between the stomach and small intestine. The goal is to safely improve the ability to eat…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 26, 2026 03:12 UTC
-
New pain device zaps away suffering without the pins and needles
Symptom relief OngoingThis study tests a spinal cord stimulator that treats chronic pain without causing tingling sensations. About 177 adults with long-term back and limb pain will use the device. The goal is to see if it cuts pain by at least half after three months.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
Spinal zaps aim to ease diabetic limb pain
Symptom relief OngoingThis study tests whether spinal cord stimulation (SCS) can reduce chronic limb pain caused by diabetic peripheral neuropathy. About 28 people with diabetes and severe leg or foot pain will receive SCS and report their pain relief over 12 months. The goal is to see if this nerve-s…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC
-
Gel shield may protect bowel during prostate radiation
Symptom relief OngoingThis study tests a gel called SpaceOAR Vue that is placed between the prostate and the bowel before radiation therapy. The goal is to see if it lowers the chance of bowel problems after treatment. About 500 men with intermediate-risk prostate cancer are taking part.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC
-
2000 heart patients monitored to see if approved stent holds up in daily life
Knowledge-focused OngoingThis study watches 2000 people in China who get a SYNERGY stent to open blocked heart arteries. Researchers want to see how often major heart problems happen after the procedure. It is not testing a new treatment, just checking how well the approved device works in everyday medic…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
Camera peers into pancreas to catch sneaky tumors
Knowledge-focused OngoingThis study looks at whether using a small camera inside the pancreas during surgery can find hidden tumors that standard scans might miss. About 100 adults with a precancerous pancreas condition called IPMN will take part. The goal is to gather information to design a larger, mor…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC
-
Tiny heart monitor tracks heart failure clues
Knowledge-focused OngoingThis study uses a small device implanted under the skin to collect information from people with heart failure. The goal is to learn more about how heart failure changes over time. About 525 adults with moderate heart failure will take part. The data gathered may help doctors bett…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC
-
Study of new bile duct tool pulled before any patients enrolled
Knowledge-focused TerminatedThis study was designed to test a new medical device for draining blocked bile ducts in people with cancer. The device was meant to help doctors access the bile duct using an ultrasound-guided scope. However, the study was withdrawn before any patients were enrolled, so no result…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC
-
Heart ablation secrets revealed: new registry aims to perfect AFib procedure
Knowledge-focused OngoingThis study looks at how doctors use the FARAPULSE system to treat atrial fibrillation (an irregular heartbeat) in routine care. Researchers will collect information from about 524 patients to see which steps before, during, and after the procedure work best. The goal is to find t…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 03:03 UTC
-
Single-Use scope study pulled before it began
Knowledge-focused TerminatedThis study planned to test a disposable duodenoscope (Exalt D) in up to 35 people undergoing ERCP, a procedure to examine the bile and pancreatic ducts. The goal was to see if the single-use scope could complete the procedure without switching to a reusable one. However, the stud…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC